Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-23

FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOVOLIN N (HUMAN INSULIN)

Snippet

SUPPL AP for NOVOLIN N (HUMAN INSULIN)